Show simple item record

dc.creatorRistovski-Kornić, Danijela
dc.creatorStefanović, Aleksandra
dc.creatorKotur-Stevuljević, Jelena
dc.creatorZeljković, Aleksandra
dc.creatorSpasojević-Kalimanovska, Vesna
dc.creatorVekić, Jelena
dc.creatorMiljković, Milica
dc.creatorParipović, Dušan
dc.creatorPeco-Antić, Amira
dc.creatorJelić-Ivanović, Zorana
dc.date.accessioned2019-09-02T12:01:21Z
dc.date.available2019-09-02T12:01:21Z
dc.date.issued2017
dc.identifier.issn1452-8258
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/2956
dc.description.abstractBackground: The aim of this study was to explore oxidative stress status, especially the enzyme myeloperoxidase in children with end-stage renal disease. Also, we investigated possible associations between the atherogenic index of plasma and these parameters. Methods: Lipid status parameters, oxidative stress status parameters, and myeloperoxidase concentration were measured in the sera of 20 children in the last stage of chronic renal disease (ESRD) and 35 healthy children of matching age and sex. The Atherogenic Index of Plasma (AIP) was calculated according to the appropriate equation. Results: We did not find any significant differences in myeloperoxidase concentrations between the investigated groups (p = 0.394). Oxidative stress parameters were, however, significantly higher in the patient group (p lt 0.001), as well as the atherogenic index of plasma (p lt 0.001). Myelo per oxidase concentration and advanced oxidation protein product (AOPP) concentration were independently associated with increased AIP in the patient group (p lt 0.05). Conclusions: Changes in AIP in children with ERSD are associated with the oxidative stress status and myeloper oxidase concentration.en
dc.publisherDruštvo medicinskih biohemičara Srbije, Beograd i Versita
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS//
dc.rightsopenAccess
dc.sourceJournal of Medical Biochemistry
dc.titleAssociation of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Diseaseen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractСтефановић, Aлександра; Спасојевић-Калимановска, Весна; Векић, Јелена; Јелић-Ивановић, Зорана; Париповић, Душан; Котур-Стевуљевић, Јелена; Ристовски-Корнић, Данијела; Зељковић, Aлександра; Миљковић, Милица; Пецо-Aнтић, Aмира;
dc.citation.volume36
dc.citation.issue1
dc.citation.spage23
dc.citation.epage31
dc.citation.other36(1): 23-31
dc.citation.rankM23
dc.identifier.wos000393585400004
dc.identifier.doi10.1515/jomb-2016-0027
dc.identifier.pmid28680346
dc.identifier.scopus2-s2.0-85011304718
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs//bitstream/id/1568/2954.pdf
dc.identifier.rcubconv_3759
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record